Schiff Center for Liver Diseases

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Primary biliary cholangitis1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Inventiva Pharma1 trial
• Mirum Pharmaceuticals, Inc.1 trial
• Vertex Pharmaceuticals Incorporated1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

  NCT05050136· Phase 2· Mirum Pharmaceuticals, Inc.· Source

• Active, not recruiting

  A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

  NCT04849728· Phase 3· Inventiva Pharma· Source

Closed trials

• Completed

  Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities

  NCT06794996· Phase 2· Vertex Pharmaceuticals Incorporated· Source